enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. 2010 DePuy Hip Recall - Wikipedia

    en.wikipedia.org/wiki/2010_DePuy_Hip_Recall

    The 2010 DePuy Hip Replacement Recall was instituted when DePuy Orthopaedics, Inc., a division of Johnson & Johnson, recalled its ASR XL Acetabular metal-on-metal hip replacement system on August 24, 2010. [1][2]

  3. DePuy Synthes - Wikipedia

    en.wikipedia.org/wiki/DePuy_Synthes

    DePuy Synthes (/ dəˈpjuː /) is a franchise of orthopaedic and neurosurgery companies. Acquired by Johnson & Johnson in 1998, its companies form part of the Johnson & Johnson Medical Devices group. DePuy develops and markets products under the Codman, DePuy Mitek, DePuy Orthopaedics and DePuy Spine brands.

  4. Johnson & Johnson - Wikipedia

    en.wikipedia.org/wiki/Johnson_&_Johnson

    On August 24, 2010, DePuy, a subsidiary of American giant Johnson & Johnson, recalled its ASR (articular surface replacement) hip prostheses from the market. DePuy said the recall was due to unpublished National Joint Registry data showing a 12% revision rate for resurfacing at five years and an ASR XL revision rate of 13%.

  5. Johnson & Johnson's OneTouch Proves Not All Recalls Are Alike

    www.aol.com/2013/03/26/johnson-johnsons-onetouch...

    Between its massive over-the-counter children's medicines recall back in 2010 to its recent headache-inducing hip implant recalls, J&J. Johnson & Johnson investors have had enough with the word ...

  6. Johnson & Johnson Fights Charges of Recalls and Kickbacks - AOL

    www.aol.com/2010/01/19/johnson-and-johnson...

    Johnson & Johnson (JNJ) shares are rebounding today, up nearly 1.5% to $65.51. The drugmaker is trying to recover from a rough week, when the Justice Department charged it with paying kickbacks to ...

  7. Johnson & Johnson Earnings Rise, but Guidance Lowered ... - AOL

    www.aol.com/2010/07/20/johnson-and-johnson...

    Johnson & Johnson's (JNJ) earnings for the second quarter of 2010 rose 5.4% to $3.4 billion, or $1.23 per share, from $3.2 billion or $1.15 per share, the company announced Tuesday morning.

  8. America’s Most Admired Lawbreaker - The Huffington Post

    highline.huffingtonpost.com/miracleindustry/...

    With consumer products from Band-Aids to baby powder, Neutrogena to Rogaine, Listerine to Visine, Aveeno to Tylenol and Sudafed to Splenda, Johnson & Johnson is the biggest and, according to multiple surveys, most admired corporation in the world’s most prosperous industry—healthcare. But the real money—about 80 percent of its revenue and ...

  9. List of SJS-inducing substances - Wikipedia

    en.wikipedia.org/wiki/List_of_SJS-inducing...

    This is a list of drugs and substances that are known or suspected to cause Stevens–Johnson syndrome This is a dynamic list and may never be able to satisfy particular standards for completeness. You can help by adding missing items with reliable sources .